Gastrointestinal Cancer News

Progress has been made across the United States to pass and implement legislative solutions to prevent and fight cancer, according to an American Cancer Society Cancer Action Network report.

Health Care Service Corp., the fourth largest health insurer in the U.S., and Florida Blue have updated their medical policies to cover Cologuard, the FDA-approved multi-target stool DNA test for noninvasive colorectal cancer screening, the manufacturer announced.

A federal report released in July showed HPV–associated head and neck cancers are on the rise among men in the United States.

An estimated 900,000 cases of venous thromboembolism are diagnosed each year in the United States, according to CDC statistics.

The rapid development of gene sequencing and targeted cancer treatments has allowed oncologists to deliver highly effective personalized therapies with near-pinpoint accuracy, killing tumor cells and sparing healthy ones.

More than 50 patient advocacy organizations from two dozen countries gathered in Florida for the inaugural World Pancreatic Cancer Coalition meeting.

The prevalence of obesity increased more rapidly from 1997 to 2014 among patients with cancer than in the general population, according to the results of a population-based study.

Biphenotypic primary liver carcinoma — also called hepatocholangiocarcinoma — may be misclassified as hepatocellular carcinoma if interpretation is based on major imaging features alone and not additional ancillary features, according to recent findings published in the American Journal of Roentgenology.

Patients with hepatocellular carcinoma were more likely to be placed on liver transplant waitlists than other patients with end-stage liver disease, according to recent findings published in Clinical Gastroenterology and Hepatology.

Providing educational interventions and free fecal immunochemical test kits to black residents in Florida resulted in an 86.7% screening completion rate, according to data published in Cancer.